Results 171 to 180 of about 2,758 (199)

Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial

Lancet Respiratory Medicine,the, 2023
Djillali Annane
exaly  

Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension

Journal of Neurology, 2023
Andreas Meisel, Djillali Annane, Tuan Vu
exaly  

Phase 3 Study of Subcutaneous Versus Intravenous Ravulizumab in Eculizumab-Experienced Adult Patients with PNH: Primary Analysis and 1-Year Follow-Up

Advances in Therapy, 2022
Mustafa Nuri Yenerel, Wolfgang Füreder, Stephan Ortiz   +2 more
exaly  

The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment

Kidney International, 2020
Eric Rondeau, Gema Ariceta, Nils Heyne
exaly  

Long‐term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2‐year results from two pivotal phase 3 studies

European Journal of Haematology, 2022
Austin G Kulasekararaj, Morag Griffin, Saskia Langemeijer   +2 more
exaly  

Mycophenolate-mofetil/ravulizumab/steroids

Reactions Weekly, 2023
openaire   +1 more source

Ravulizumab in neuer Konzentration zugelassen

InFo Hämatologie + Onkologie, 2021
openaire   +1 more source

Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies

British Journal of Haematology, 2020
Régis Peffault de Latour, Robert A Brodsky, Stephan Ortiz   +2 more
exaly  

Ravulizumab for COVID-19 Kidney Injury

Journal of the American Society of Nephrology, 2022
Aliza Anwar Memon, Hasban Ahmed, Andrew M. Siedlecki   +2 more
openaire   +1 more source

Ravulizumab in Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder

Annals of Neurology, 2023
Sean J Pittock, Jeffrey L Bennett, Achim Berthele   +2 more
exaly